Submitted by dcc on Wed, 2020-04-15 10:51 Study Title: A Phase III Randomized Trial of Radiation +/- MK-3475 (Pembrolizumab) for Newly Diagnosed Early Stage High Intermediate Risk Mismatch Repair Deficient (dMMR) Endometrioid Endometrial CancerCIRB: Adult CIRB - Late Phase EmphasisLead Group: NRGStatus: ActiveReview Status: Available to Open
